Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Strata Oncology logo — company profile

Strata Oncology

Founded 2016 United States Ann Arbor, United States 31 employees Series C Total: $128.00M Biotechnology, Health Care +1

General Information

Company Name Strata Oncology
Founded Year 2016
Location United States Ann Arbor, United States
Employees 31
Industries Biotechnology, Health Care, Medical Devices
Funding Stage Series C
Social

BounceWatch is an independent company data service, not affiliated with Strata Oncology. To contact Strata Oncology, visit strataoncology.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Strata Oncology compare?

A PDF of Strata Oncology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Strata Oncology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Strata Oncology

Strata Oncology is a high-growth, state-of-the-art, precision oncology company, founded in 2016 and headquartered in the United States. The company's mission is to deliver a new standard of care in cancer treatment by integrating molecular profiling, decision support, and clinical trial participation into routine practice. Strata Oncology partners with major healthcare systems across the country to conduct genomic sequencing of cancer patients' biopsies at their high-throughput CLIA lab. With a recent $90.00M Series C investment on 28 July 2021, the company has attracted a strong group of investors including Arboretum Ventures, Baird Capital, Renaissance Venture Capital, Wellington Management, Cormorant Asset Management, Deerfield Management, Highline Capital, Monashee Investment Management, Pfizer Venture Investments, and Merck Global Health Innovation Fund. The unique approach of providing rapid results to oncologists, indicating tumor profiles, and matching appropriate therapies and drug trials, accelerates the move to personalized medicine. Strata Oncology's commitment is further emphasized by their passionate team of clinicians, pathologists, bioinformaticists, software engineers, lab technicians, and more, all working towards making a positive difference in the lives of cancer patients and their families. The recent Series C investment will likely allow Strata Oncology to expand its reach and further advance its innovative solutions, shaping the future of cancer care.

Business keywords: Precision oncology, Cancer care, Molecular profiling, Genomic sequencing, Clinical trials, Personalized medicine, Biopsies, High-throughput CLIA lab, Drug trials, Healthcare systems, Precision medicine, Next-generation sequencing, Bioinformatics, Health technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series C $90.00M 10
Arboretum Ventures Baird Capital Renaissance Venture Capital
Arboretum Ventures, Baird Capital +8
28 Jul 2021
Series B $26.00M -
23 May 2018
Series A $12.00M -
01 Jun 2016

Strata Oncology Alternatives & Competitors

View All Alternatives
Strata Oncology vs
Agendia
Agendia United States

MammaPrint® + BluePrint® provides you with actionable insights throughout your patient’s breast canc...

Private Equity
209 employees
Biotechnology, Health Care
Compare Strata Oncology vs Agendia
Strata Oncology vs
Helix
Helix United States

Helix is the leading population genomics and precision health organization.

Series C
622 employees
Big Data, Biotechnology
Compare Strata Oncology vs Helix
Strata Oncology vs
Pierian
Pierian United States

Genomics in Practice

Venture round
55 employees
Biotechnology, Health Care
Also compare with: Strata Oncology vs Aster Insights Aster Insights View all alternatives

FAQ About Strata Oncology

Strata Oncology is a high-growth, state-of-the art, precision oncology company, delivering a new standard of care that integrates molecular profiling, decision support and clinical trial participation into routine practice. We do this by partnering with major healthcare systems across the country,...
Strata Oncology was founded in 2016.
Strata Oncology is headquartered in Ann Arbor, United States.
Strata Oncology operates in Biotechnology, Health Care and Medical Devices. Its work centres on Precision oncology, Cancer care, Molecular profiling and Genomic sequencing.
Strata Oncology has approximately 31 employees.
Strata Oncology has completed 3 funding rounds, raising a total of $128.00M. The latest funding stage is Series C.
Top alternatives and competitors to Strata Oncology include Agendia, Helix, Pierian, Helomics, Geneseeq Technology Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Strata Oncology and Agendia are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Strata Oncology, https://bouncewatch.com/company/strata-oncology, updated 10 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout